
|Podcasts|March 2, 2022
S4E3: Myfembree for moderate-to-severe endometriosis pain: Potential for adolescents
Author(s)Lindsey Carr, Editor, Jessica Y. Shim, MD
In this episode of Pap Talk, Contemporary OB/GYN® Associate Editor Lindsey Carr sat down with Jessica Shim, MD, an attending at in the Division of Gynecology, Department of Surgery, Boston Children’s Hospital; Harvard Medical School Boston, Massachusetts, to discuss Myfembree (relugolix, estradiol, and norethindrone acetate tablets; Myovant Sciences, Pfizer) and its possible approval in May 2022.
Advertisement
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
HRSA updates cervical cancer screening guidelines
2
Interim safety data of RSVpreF vaccination during pregnancy, with Ashley Michnick, PharmD, PhD
3
Minimum wage increases linked to lower rates of maternal hypertensive disorders
4
FDA document review details evidence-based oversight of mifepristone
5











